Abingdon
United Kingdom
17
2018-05-10
The entities that hold a legal rights for patent applications filed by inventor Davies Stephen John:
Stephen John Davies from Abingdon, GB has applied for patents for these inventions. The list has both pending applications and granted patents:
Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof
#2 | 2017-06-082-AMINOPYRAZINE DERIVATIVES AS CSF-1 R KINASE INHIBITORS
#3 | 2016-10-13Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof
#4 | 2016-06-02Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters
#5 | 2015-12-242-aminopyrazine derivatives as CSF-1R kinase inhibitors
#6 | 2015-09-03Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof
#7 | 2014-06-12Enzyme inhibitors
#8 | 2014-03-27ENZYME AND RECEPTOR MODULATION
#9 | 2014-01-09IMAGING AGENTS
#10 | 2013-05-09Enzyme inhibitors
#11 | 2011-02-10Inhibitors of P38 map kinase
#12 | 2010-11-04Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
#13 | 2010-04-08IKK-beta serine-threonine protein kinase inhibitors
#14 | 2010-03-18Inhibitors of IKK-beta serine-threonine protein kinase
#15 | 2009-11-26Enzyme inhibitors
#16 | 2009-05-21Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
#17 | 2006-12-14Derivatives of hydroxamic acid as metalloproteinase inhibitors
236475 ⎘